Christopher P. Kiritsy - Jun 21, 2023 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
Director
Signature
/s/ Ahmed Mousa, Attorney-in-Fact
Stock symbol
PIRS
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 04:46 PM
Previous filing
May 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (right to buy) Award $0 +40K $0.00 40K Jun 21, 2023 Common Stock 40K $0.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest as to 100% of the underlying shares on the date of the Company's 2024 annual stockholders meeting, subject to the Reporting Person's continued service as a director through the vesting date.